Apogee Therapeutics to Host Inaugural Virtual R&D Day on December 2, 2024

GlobeNewswireNov 18 20:30

Apogee Therapeutics (NASDAQ:APGE) Is In A Good Position To Deliver On Growth Plans

Yahoo FinanceNov 14 20:22

BTIG Maintains Apogee Therapeutics(APGE.US) With Buy Rating, Maintains Target Price $100

Futu NewsNov 13 19:31 · Ratings

Apogee Therapeutics Shares Are Trading Lower. The Company Reported Q3 Financial Results.

BenzingaNov 13 02:50

Promising Advancements and Strategic Positioning Propel Apogee Therapeutics, Inc. to a Buy Rating

TipRanksNov 13 02:35 · Ratings

Apogee Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 12 22:31 · Announcements